These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33173919)

  • 21. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
    Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
    JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Geographic and demographic heterogeneity of SARS-CoV-2 diagnostic testing in Illinois, USA, March to December 2020.
    Holden TM; Richardson RAK; Arevalo P; Duffus WA; Runge M; Whitney E; Wise L; Ezike NO; Patrick S; Cobey S; Gerardin J
    BMC Public Health; 2021 Jun; 21(1):1105. PubMed ID: 34107947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic.
    Charlton CL; Nguyen LT; Bailey A; Fenton J; Plitt SS; Marohn C; Lau C; Hinshaw D; Lutsiak C; Simmonds K; Kanji JN; Zelyas N; Lee N; Mengel M; Tipples G
    Microbiol Spectr; 2021 Sep; 9(1):e0029121. PubMed ID: 34406813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mobility as a driver of severe acute respiratory syndrome coronavirus 2 in cancer patients during the second coronavirus disease 2019 pandemic wave.
    Fong D; Mair MJ; Lanthaler F; Alber M; Mitterer M
    Int J Cancer; 2022 Feb; 150(3):431-439. PubMed ID: 34610144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mobility gap: estimating mobility thresholds required to control SARS-CoV-2 in Canada.
    Brown KA; Soucy JR; Buchan SA; Sturrock SL; Berry I; Stall NM; Jüni P; Ghasemi A; Gibb N; MacFadden DR; Daneman N
    CMAJ; 2021 Apr; 193(17):E592-E600. PubMed ID: 33827852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Association Between Neighborhood Social Vulnerability and COVID-19 Testing, Positivity, and Incidence in Alabama and Louisiana.
    Oates GR; Juarez LD; Horswell R; Chu S; Miele L; Fouad MN; Curry WA; Fort D; Hillegass WB; Danos DM
    J Community Health; 2021 Dec; 46(6):1115-1123. PubMed ID: 33966116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laboratory surveillance for SARS-CoV-2 in India: Performance of testing & descriptive epidemiology of detected COVID-19, January 22 - April 30, 2020.
    ; ; ;
    Indian J Med Res; 2020 May; 151(5):424-437. PubMed ID: 32611914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020.
    Zambrano LD; Ellington S; Strid P; Galang RR; Oduyebo T; Tong VT; Woodworth KR; Nahabedian JF; Azziz-Baumgartner E; Gilboa SM; Meaney-Delman D;
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(44):1641-1647. PubMed ID: 33151921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk Factors for Testing Positive for Severe Acute Respiratory Syndrome Coronavirus 2 in a National United States Healthcare System.
    Fan VS; Dominitz JA; Eastment MC; Locke ER; Green P; Berry K; O'Hare AM; Shah JA; Crothers K; Ioannou GN
    Clin Infect Dis; 2021 Nov; 73(9):e3085-e3094. PubMed ID: 33105485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High anti-SARS-CoV-2 antibody seroconversion rates before the second wave in Manaus, Brazil, and the protective effect of social behaviour measures: results from the prospective DETECTCoV-19 cohort.
    Lalwani P; Araujo-Castillo RV; Ganoza CA; Salgado BB; Pereira Filho IV; da Silva DSS; de Morais TBDN; Jordão MF; Ortiz JV; Barbosa ARC; Sobrinho WBS; Cordeiro IB; de Souza Neto JN; de Assunção EN; da Costa CF; de Souza PE; de Albuquerque BC; Astofi-Filho S; ; Lalwani JDB
    Lancet Glob Health; 2021 Nov; 9(11):e1508-e1516. PubMed ID: 34678195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
    Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
    BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
    Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
    JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Socioeconomic Disparities in Severe Acute Respiratory Syndrome Coronavirus 2 Serological Testing and Positivity in New York City.
    Lieberman-Cribbin W; Galanti M; Shaman J
    Open Forum Infect Dis; 2021 Dec; 8(12):ofab534. PubMed ID: 34877365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Real-time Tracking of Nonpharmaceutical Interventions and Their Association With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity: The Coronavirus Disease 2019 (COVID-19) Pandemic Pulse Study.
    Clipman SJ; Wesolowski AP; Gibson DG; Agarwal S; Lambrou AS; Kirk GD; Labrique AB; Mehta SH; Solomon SS
    Clin Infect Dis; 2021 Oct; 73(7):e1822-e1829. PubMed ID: 32877921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.